|
Market Closed -
Nasdaq
04:00:00 2026-10-28 pm EDT
|
5-day change | 1st Jan Change | ||
| 61.42 USD | -0.15% |
|
+6.50% | +55.26% |
| Sep. 24 | Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing | MT |
| Sep. 21 | AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 1000 | CI |
Company Valuation: AtriCure, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,194 | 2,064 | 1,692 | 1,490 | 1,967 | 3,124 | - | - |
| Change | - | -35.37% | -18.05% | -11.92% | 32.01% | 58.85% | - | - |
| Enterprise Value (EV) 1 | 3,210 | 2,063 | 1,623 | 1,441 | 1,873 | 2,972 | 2,898 | 2,803 |
| Change | - | -35.73% | -21.32% | -11.21% | 29.97% | 58.71% | -2.51% | -3.25% |
| P/E | 63.8x | -43.5x | -54.1x | -32.2x | -165x | 575x | 146x | 88.2x |
| PBR | 6.61x | 4.52x | 3.55x | 3.24x | 4x | 5.4x | 4.81x | 4.21x |
| PEG | - | 0x | 1.5x | -0.7x | 2.2x | -4x | 0x | 1.3x |
| Capitalization / Revenue | 11.6x | 6.25x | 4.24x | 3.2x | 3.68x | 5.15x | 4.59x | 4.08x |
| EV / Revenue | 11.7x | 6.24x | 4.06x | 3.1x | 3.5x | 4.9x | 4.26x | 3.66x |
| EV / EBITDA | -366x | -943x | 83.5x | 46.3x | 30.3x | 34x | 28.4x | 22.7x |
| EV / EBIT | -67.9x | -48.3x | -60.8x | -36x | -198x | 259x | 116x | 66.8x |
| EV / FCF | -136x | -52.9x | -216x | 1,934x | 38.8x | 56.4x | 71.4x | - |
| FCF Yield | -0.73% | -1.89% | -0.46% | 0.05% | 2.58% | 1.77% | 1.4% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.09 | -1.02 | -0.66 | -0.95 | -0.24 | 0.1068 | 0.4206 | 0.6966 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 274.3 | 330.4 | 399.2 | 465.3 | 534.5 | 606.3 | 680.2 | 765.3 |
| EBITDA 1 | -8.776 | -2.188 | 19.45 | 31.12 | 61.77 | 87.49 | 102 | 123.7 |
| EBIT 1 | -47.3 | -42.67 | -26.68 | -40.01 | -9.447 | 11.46 | 25.02 | 41.98 |
| Net income 1 | 50.2 | -46.47 | -34.85 | -44.7 | -11.45 | 7.132 | 20.89 | 35.13 |
| Net Debt 1 | 16.09 | -1.265 | -68.63 | -49 | -94.05 | -151.9 | -226.6 | -320.8 |
| Reference price 2 | 69.53 | 44.38 | 35.69 | 30.56 | 39.56 | 61.42 | 61.42 | 61.42 |
| Nbr of stocks (in thousands) | 45,932 | 46,508 | 47,395 | 48,753 | 49,717 | 50,866 | - | - |
| Announcement Date | 2/15/22 | 2/21/23 | 2/15/24 | 2/12/25 | 2/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 575.77x | 4.91x | 34.02x | -.--% | 3.13B | |
| 34.11x | 4.04x | 15.18x | 2.52% | 178B | |
| 23.4x | 4.6x | 16.03x | 1.19% | 116B | |
| 20.08x | 3.49x | 12.5x | 3.02% | 115B | |
| 31.91x | 3.07x | 12.4x | 2.23% | 93.1B | |
| 17.84x | 0.21x | 12.94x | 0.73% | 62.09B | |
| 31.75x | 7.96x | 20.45x | 1.24% | 55.87B | |
| 38.68x | 3.58x | 12.18x | 2.14% | 53.12B | |
| 38.02x | 9.44x | 26.4x | -.--% | 44.22B | |
| 40.3x | 3.26x | 12.16x | 0.53% | 33.59B | |
| Average | 85.19x | 4.46x | 17.43x | 1.36% | 75.41B | |
| Weighted average by Cap. | 31.62x | 4.15x | 15.16x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ATRC Stock
- Valuation AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
